Autism medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
== | Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | ||
==Overview== | |||
Many medications are used to treat problems associated with ASD.<ref>{{cite journal |journal= Harv Rev Psychiatry |date=2008 |volume=16 |issue=2 |pages=97–112 |title= Pharmacological treatment options for autism spectrum disorders in children and adolescents |author= Leskovec TJ, Rowles BM, Findling RL |doi=10.1080/10673220802075852 |pmid=18415882}}</ref> More than half of U.S. children diagnosed with ASD are prescribed [[psychoactive drug]]s or [[anticonvulsant]]s, with the most common drug classes being [[antidepressant]]s, [[stimulant]]s, and [[antipsychotic]]s.<ref>{{cite journal |journal= J Child Adolesc Psychopharmacol |date=2007 |volume=17 |issue=3 |pages=348–55 |title= Medication use among children with autism spectrum disorders |author= Oswald DP, Sonenklar NA |doi=10.1089/cap.2006.17303 |pmid=17630868}}</ref> Aside from antipsychotics,<ref>{{cite journal |journal= J Clin Invest |date=2008 |volume=118 |issue=1 |pages=6–14 |title= Antipsychotics in the treatment of autism |author= Posey DJ, Stigler KA, Erickson CA, McDougle CJ |doi=10.1172/JCI32483 |pmid=18172517 |url=http://jci.org/cgi/content/full/118/1/6}}</ref> there is scant reliable research about the effectiveness or safety of drug treatments for adolescents and adults with ASD.<ref>Lack of research on drug treatments: | Many medications are used to treat problems associated with ASD.<ref>{{cite journal |journal= Harv Rev Psychiatry |date=2008 |volume=16 |issue=2 |pages=97–112 |title= Pharmacological treatment options for autism spectrum disorders in children and adolescents |author= Leskovec TJ, Rowles BM, Findling RL |doi=10.1080/10673220802075852 |pmid=18415882}}</ref> More than half of U.S. children diagnosed with ASD are prescribed [[psychoactive drug]]s or [[anticonvulsant]]s, with the most common drug classes being [[antidepressant]]s, [[stimulant]]s, and [[antipsychotic]]s.<ref>{{cite journal |journal= J Child Adolesc Psychopharmacol |date=2007 |volume=17 |issue=3 |pages=348–55 |title= Medication use among children with autism spectrum disorders |author= Oswald DP, Sonenklar NA |doi=10.1089/cap.2006.17303 |pmid=17630868}}</ref> Aside from antipsychotics,<ref>{{cite journal |journal= J Clin Invest |date=2008 |volume=118 |issue=1 |pages=6–14 |title= Antipsychotics in the treatment of autism |author= Posey DJ, Stigler KA, Erickson CA, McDougle CJ |doi=10.1172/JCI32483 |pmid=18172517 |url=http://jci.org/cgi/content/full/118/1/6}}</ref> there is scant reliable research about the effectiveness or safety of drug treatments for adolescents and adults with ASD.<ref>Lack of research on drug treatments: | ||
*{{cite journal |journal= Aust Fam Physician |year=2007 |volume=36 |issue=9 |pages=741–4 |title= Children and autism—part 1—recognition and pharmacological management |author= Angley M, Young R, Ellis D, Chan W, McKinnon R |pmid=17915375 |url=http://www.racgp.org.au/Content/NavigationMenu/Publications/AustralianFamilyPhys/2007issues/afp200709/200709angley.pdf |format=PDF}} | *{{cite journal |journal= Aust Fam Physician |year=2007 |volume=36 |issue=9 |pages=741–4 |title= Children and autism—part 1—recognition and pharmacological management |author= Angley M, Young R, Ellis D, Chan W, McKinnon R |pmid=17915375 |url=http://www.racgp.org.au/Content/NavigationMenu/Publications/AustralianFamilyPhys/2007issues/afp200709/200709angley.pdf |format=PDF}} | ||
| Line 20: | Line 21: | ||
[[Category:Neurological disorders]] | [[Category:Neurological disorders]] | ||
[[Category:Autism]] | [[Category:Autism]] | ||
[[Category:Needs content]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 21:19, 10 February 2013
|
Autism Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Autism medical therapy On the Web |
|
American Roentgen Ray Society Images of Autism medical therapy |
|
Risk calculators and risk factors for Autism medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Many medications are used to treat problems associated with ASD.[1] More than half of U.S. children diagnosed with ASD are prescribed psychoactive drugs or anticonvulsants, with the most common drug classes being antidepressants, stimulants, and antipsychotics.[2] Aside from antipsychotics,[3] there is scant reliable research about the effectiveness or safety of drug treatments for adolescents and adults with ASD.[4] A person with ASD may respond atypically to medications, the medications can have adverse effects, and no known medication relieves autism's core symptoms of social and communication impairments.[5][6]
References
- ↑ Leskovec TJ, Rowles BM, Findling RL (2008). "Pharmacological treatment options for autism spectrum disorders in children and adolescents". Harv Rev Psychiatry. 16 (2): 97–112. doi:10.1080/10673220802075852. PMID 18415882.
- ↑ Oswald DP, Sonenklar NA (2007). "Medication use among children with autism spectrum disorders". J Child Adolesc Psychopharmacol. 17 (3): 348–55. doi:10.1089/cap.2006.17303. PMID 17630868.
- ↑ Posey DJ, Stigler KA, Erickson CA, McDougle CJ (2008). "Antipsychotics in the treatment of autism". J Clin Invest. 118 (1): 6–14. doi:10.1172/JCI32483. PMID 18172517.
- ↑ Lack of research on drug treatments:
- Angley M, Young R, Ellis D, Chan W, McKinnon R (2007). "Children and autism—part 1—recognition and pharmacological management" (PDF). Aust Fam Physician. 36 (9): 741–4. PMID 17915375.
- Broadstock M, Doughty C, Eggleston M (2007). "Systematic review of the effectiveness of pharmacological treatments for adolescents and adults with autism spectrum disorder". Autism. 11 (4): 335–48. doi:10.1177/1362361307078132. PMID 17656398.
- ↑ Template:Cite paper
- ↑ Buitelaar JK (2003). "Why have drug treatments been so disappointing?". Novartis Found Symp. 251: 235–44, discussion 245–9, 281–97. doi:10.1002/0470869380.ch14. PMID 14521196.